Overview

Pomalidomide for Myelofibrosis Patients

Status:
Completed

Trial end date:
2018-05-22

Target enrollment:

Participant gender:

Summary

The goal of this clinical research study is to learn if CC-4047 (now called pomalidomide) and prednisone can help to control MMM. The safety of this therapy will also be studied.

Phase:

Phase 2

Details

Lead Sponsor:

M.D. Anderson Cancer Center

Collaborator:

Celgene

Treatments:

Pomalidomide
Prednisone
Thalidomide